메뉴 건너뛰기




Volumn 19, Issue 3, 2001, Pages 225-233

Mitoxantrone and paclitaxel combination chemotherapy in metastatic breast cancer

Author keywords

Breast carcinoma; Metastatic; Mitoxantrone; Paclitaxel; Prognostic factors

Indexed keywords

DOXORUBICIN; MITOXANTRONE; PACLITAXEL;

EID: 0035038973     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-100102548     Document Type: Article
Times cited : (3)

References (28)
  • 6
    • 0030947405 scopus 로고    scopus 로고
    • Paclitaxel-based combination chemotherapy for breast cancer
    • (1997) Oncology , vol.11 , Issue.SUPPL. 2 , pp. 29-37
    • Hortibagyi, G.N.1
  • 8
    • 0031892696 scopus 로고    scopus 로고
    • Paclitaxel plus doxorubicin in metastatic breast cancer: The Milan experience
    • (1998) Oncology , vol.12 , pp. 13-15
    • Gianni, L.1
  • 12
    • 0031797531 scopus 로고    scopus 로고
    • Taxanes in combination with Doxorubicin in the treatment of Metastatic breast cancer
    • (1998) Semin. Oncol. , vol.25 , Issue.SUPPL. 12 , pp. 18-22
    • Dieras, V.1
  • 18
    • 0031296963 scopus 로고    scopus 로고
    • Mitoxantrone, 5-Fluorouracil and High-Dose Leucovorin (NFL) in the treatment of metastatic breast cancer: Randomized comparison to Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) and attempts to improve efficacy by adding Paclitaxel
    • (1997) Eur. J. Cancer Care (Engl.) , vol.6 , Issue.SUPPL. 4 , pp. 4-9
    • Hainsworth, J.D.1
  • 21
    • 0031043123 scopus 로고    scopus 로고
    • Treatment of advanced and relapsing breast cancer with a combination of Paclitaxel and Mitoxantrone
    • Semin. Oncol. , vol.24 , Issue.SUPPL. 3
    • Panagos, G.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.